CLINICAL EFFICACY AND SAFETY OF INFLIXIMAB - FIRST RESULTS AFTER A DECADE OF CONTINUOUS TREATMENT IN ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Baraliakos, X. [1 ]
Listing, J. [2 ]
Fritz, C. [2 ]
Haibel, H. [3 ]
Alten, R. [4 ]
Burmester, G. [5 ]
Krause, A. [6 ]
Schewe, S. [7 ]
Schneider, M. [8 ]
Soerensen, H.
Schmidt, R. [9 ]
Sieper, J. [3 ]
Braun, J. [1 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Charite, Berlin, Germany
[4] Schlosspk Klin, Berlin, Germany
[5] Charite Mitte, Berlin, Germany
[6] Immanuel Hosp, Berlin, Germany
[7] Univ Munich, Munich, Germany
[8] Univ Dusseldorf, Dusseldorf, Germany
[9] Med Univ, Hanover, NH USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [1] CLINICAL EFFICACY AND SAFETY OF INFLIXIMAB - RESULTS AFTER A DECADE OF CONTINUOUS TREATMENT IN ANKYLOSING SPONDYLTIS
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Haibel, H.
    Sieper, J.
    Braun, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 638 - 638
  • [2] Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis
    Baraliakos, Xenofon
    Listing, Joachim
    Rudwaleit, Martin
    Brandt, Jan
    Alten, Rieke
    Burmester, Gerd
    Gromnica-Ihle, Erika
    Haibel, Hildrun
    Schewe, Stephan
    Schneider, Matthias
    Soerensen, Helmut
    Zeidler, Henning
    Visvanathan, Sudha
    Sieper, Joachim
    Braun, Juergen
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (03) : 510 - 515
  • [3] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    [J]. JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [4] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [5] Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
    Braun, J
    Brandt, J
    Listing, J
    Zink, A
    Alten, R
    Burmester, G
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 229 - 234
  • [6] The efficacy of infliximab in ankylosing spondylitis
    Christopher T. Ritchlin
    [J]. Current Rheumatology Reports, 2004, 6 (2) : 96 - 96
  • [7] Efficacy and safety of infliximab in patients with ankylosing spondylitis: 102 week results of the assert trial
    Braun, J.
    Sieper, J.
    Geusens, P.
    Dijkmans, B.
    Han, J.
    Xu, W.
    Williamson, P.
    Van der Heijde, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 87 - 87
  • [8] Infliximab treatment efficacy in lymphoedema associated with ankylosing spondylitis
    Almodóvar, R
    Zarco, P
    Quirós, FJ
    Mazzucchelli, R
    [J]. RHEUMATOLOGY, 2004, 43 (11) : 1456 - 1456
  • [9] EFFICACY AND SAFETY OF LOW-DOSE INFLIXIMAB IN ANKYLOSING SPONDYLITIS
    Schaufelberger, C.
    Morck, B.
    Jacobsson, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 642 - 643
  • [10] Safety and efficacy of discontinuation and re-administration of infliximab after long term continuous therapy in patients with ankylosing spondylitis
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Sieper, J.
    Braun, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
12345